FSGS - ETF AI Analysis
Top Page
Small Cap US Equity Select ETF (FSGS)
Rating:74Outperform
Price Target:―
Positive Factors
Broad Sector Diversification
The fund spreads its investments across many sectors, which can help reduce the impact if any one industry runs into trouble.
Generally Strong Top Holdings
Most of the top 10 stocks have shown strong or steady performance this year, which has supported the ETF’s recent gains.
Positive Recent Performance
The ETF has delivered solid gains over the past month and year-to-date, suggesting its strategy has been working in the current market.
Negative Factors
Higher Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of your returns go toward fees each year.
Single-Country Concentration
Almost all of the ETF’s assets are invested in U.S. companies, offering little geographic diversification if other regions perform better.
Exposure to Volatile Small Caps
Because the ETF focuses on small U.S. companies, its share price may be more sensitive to market swings and economic slowdowns.
FSGS vs. SPDR S&P 500 ETF (SPY)
AUM29.31M
RegionNorth America
Expense Ratio0.60%
Beta0.89
IssuerFirst Trust
Inception DateJun 20, 2017
Dividend Yield0.03%
Asset ClassEquity
Index TrackedSMID Growth Strength Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume964
30 Day Avg. Volume1,103
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
39.41Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering100
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FSGS Summary
FSGS, the Small Cap US Equity Select ETF, tracks the SMID Growth Strength Index and focuses on smaller U.S. companies with room to grow. It spreads investments across many areas like technology, health care, and financials, giving you exposure to fast-growing, lesser-known businesses. Some of its top holdings include DigitalOcean Holdings and Neurocrine, which are involved in cloud services and pharmaceuticals. An investor might choose this ETF to seek long-term growth and diversify beyond large, well-known stocks. However, small-cap stocks can be more volatile, so the ETF’s value can rise and fall more sharply than the overall market.
How much will it cost me?The Small Cap US Equity Select ETF (Ticker: FSGS) has an expense ratio of 0.6%, which means you’ll pay $6 per year for every $1,000 invested. This is higher than average because the ETF is actively managed, focusing on small-cap companies with growth potential, which requires more research and management effort.
What would affect this ETF?The Small Cap US Equity Select ETF (FSGS) could benefit from economic growth and innovation in the U.S., particularly in technology and financial sectors, which are its largest exposures. However, it may face challenges from rising interest rates or economic slowdowns, which can negatively impact small-cap companies and growth-focused investments. Regulatory changes or sector-specific disruptions could also influence the performance of its top holdings.
FSGS Top 10 Holdings
FSGS is leaning heavily into U.S. small-cap growth, with tech and health care names setting the tone. Halozyme, Veeva Systems, and Inspire Medical Systems have been rising, acting as key engines for recent performance, while Elastic and Manhattan Associates look a bit tired, with more mixed, lagging action of late. DocuSign sits in the middle of the pack, steady but not exactly stealing the show. Overall, the fund is clearly tilted toward innovative U.S. companies, especially in technology and health care, rather than a broad global mix.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Elastic | 1.57% | $460.80K | $10.31B | 13.59% | 65 Neutral | |
| PTC | 1.54% | $451.71K | $21.12B | -1.24% | 73 Outperform | |
| Veeva Systems | 1.49% | $437.98K | $47.95B | 3.33% | 66 Neutral | |
| Abercrombie Fitch | 1.48% | $432.45K | $6.05B | 94.36% | 78 Outperform | |
| Halozyme | 1.40% | $409.99K | $12.53B | 72.26% | 73 Outperform | |
| Doximity | 1.40% | $409.49K | $5.44B | -53.51% | 72 Outperform | |
| Inspire Medical Systems | 1.34% | $393.36K | $1.99B | -8.35% | 73 Outperform | |
| DocuSign | 1.33% | $389.45K | $13.29B | 3.92% | 71 Outperform | |
| Heritage Insurance Holdings | 1.27% | $372.16K | $1.04B | 37.45% | 72 Outperform | |
| InterDigital | 1.25% | $367.42K | $8.55B | -2.53% | 76 Outperform |
FSGS Technical Analysis
Positive
―
Price Trends
33.05
Negative
32.30
Positive
31.42
Positive
Market Momentum
-0.12
Negative
50.17
Neutral
86.97
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FSGS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.25, equal to the 50-day MA of 33.05, and equal to the 200-day MA of 31.42, indicating a neutral trend. The MACD of -0.12 indicates Negative momentum. The RSI at 50.17 is Neutral, neither overbought nor oversold. The STOCH value of 86.97 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FSGS.
FSGS Peer Comparison
Comparison Results
Performance Comparison
FSGS
Small Cap US Equity Select ETF
32.50
1.38
4.43%
OASC
OneAscent Small Cap Core ETF
―
―
―
CVSM
CresAlta Small and Mid-Cap ETF
―
―
―
FSCS
First Trust Smid Capital Strength Etf
―
―
―
SSMG
Virtus Silvant Small/Mid Growth ETF
―
―
―
PCSG
Polen 5Perspectives Small-Mid Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents